FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for RECLAST (zoledronic acid) filed by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer with Bone Metastases
• Hypercalcemia of Malignancy
• Multiple Myeloma
• Osteoporosis
• Paget Disease of Bone
• Prostate Cancer

Drugs mentioned

• RECLAST (ZOLEDRONIC ACID)

Snippet

SUPPL AP for RECLAST (ZOLEDRONIC ACID)